Search

everythinglearnresearchcommunity

for

Search:↓

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Travoprost can help eyelash growth but may cause darkening around the eyes.

Baricitinib is effective and safe for treating severe alopecia areata.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

COVID-19 infection may trigger alopecia areata in some patients.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Acitretin can cause eyebrow and eyelash hair loss.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Facial hair loss and psychosocial issues are crucial in deciding treatment for alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Alopecia areata severity and symptoms vary by race and ethnicity.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

The SBN system effectively assesses alopecia areata severity and predicts its course.